These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 35126237)

  • 1. Corporate Competing Culture and Environmental Investment.
    Tian J; Cao W; Cheng Q; Huang Y; Hu S
    Front Psychol; 2021; 12():774173. PubMed ID: 35126237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is Cross-Shareholding Conducive to Corporate Sustainability? Evidence From the Environmental Investment of Chinese Listed Firms.
    Tian J; Cao W; Ji X
    Front Psychol; 2021; 12():789811. PubMed ID: 34803864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does digital finance improve the green investment of Chinese listed heavily polluting companies? The perspective of corporate financialization.
    Jiang Y; Guo C; Wu Y
    Environ Sci Pollut Res Int; 2022 Oct; 29(47):71047-71063. PubMed ID: 35595899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does Entrepreneurs' Military Experience Promote Corporate Environmental Investment? Evidence from Chinese Private Firms.
    Hong C; Yan Y; Zhang X
    Int J Environ Res Public Health; 2022 Feb; 19(4):. PubMed ID: 35206291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Financial performance of China's listed firms in presence of coronavirus: Evidence from corporate culture and corporate social responsibility.
    Zheng F; Zhao Z; Sun Y; Khan YA
    Curr Psychol; 2023; 42(11):8897-8918. PubMed ID: 34400856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted poverty alleviation initiatives and corporate sustainable value creation: Determining the role of corporate internal governance control in China.
    Bin-Feng C; Zhe L; Mirza SS; Safdar R
    Heliyon; 2023 Jul; 9(7):e17686. PubMed ID: 37449183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Environmental legislation and capitalization of corporate environmental expenditure: Evidence from China.
    Wang T; Chen Y
    PLoS One; 2022; 17(11):e0277258. PubMed ID: 36327347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 Outbreak and Financial Performance of Chinese Listed Firms: Evidence From Corporate Culture and Corporate Social Responsibility.
    Sun Y; Li Y
    Front Public Health; 2021; 9():710743. PubMed ID: 34604155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do institutional contingencies matter for green investment?-An institution based view of Chinese listed companies.
    Khan FU; Zhang J; Saeed I; Ullah S
    Heliyon; 2024 Jan; 10(1):e23456. PubMed ID: 38173482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does environmental regulation truly enhance corporate green environmental investment? Evidence from the supervision of independent directors in listed companies.
    Wang C; Wang F; Jiang P
    Front Psychol; 2024; 15():1430137. PubMed ID: 39315041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Green finance and corporate environmental responsibility: evidence from heavily polluting listed enterprises in China.
    He L; Zhong T; Gan S
    Environ Sci Pollut Res Int; 2022 Oct; 29(49):74081-74096. PubMed ID: 35643997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Environmental regulation and green innovation of polluting firms in China.
    He L; Wang M
    PLoS One; 2023; 18(3):e0281303. PubMed ID: 36893093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do the Age and Gender of Chairperson Affect Firms' Environmental Protection Investment?
    Han L; Peng C
    Int J Environ Res Public Health; 2022 Nov; 19(21):. PubMed ID: 36361371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do environmental, social, and governance scores improve green innovation? Empirical evidence from Chinese-listed companies.
    Zhang C; Chen D
    PLoS One; 2023; 18(5):e0279220. PubMed ID: 37228130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corporate environmental governance scheme and investment efficiency over the course of COVID-19.
    Liu H; Jiang J; Xue R; Meng X; Hu S
    Financ Res Lett; 2022 Jun; 47():102726. PubMed ID: 35185400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does green innovation facilitate firms' access to trade credit?
    Liu Q; Tang J
    Environ Sci Pollut Res Int; 2023 Dec; 30(57):120683-120706. PubMed ID: 37945952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Environmental, social, and governance (ESG) performance and financial outcomes: Analyzing the impact of ESG on financial performance.
    Chen S; Song Y; Gao P
    J Environ Manage; 2023 Nov; 345():118829. PubMed ID: 37688968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From ratings to action: The impact of ESG performance on corporate innovation.
    Wang Y; Wang X
    Heliyon; 2024 Feb; 10(4):e26683. PubMed ID: 38420449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can semi-mandatory non-financial disclosure requirements drive firms to improve ESG performance - evidence from Chinese listed companies.
    Wu L; Lam JFI; Liu Y
    Heliyon; 2024 Jul; 10(14):e34235. PubMed ID: 39113963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unveiling the Effectiveness of Agency Cost and Firms' Size as Moderators Between CSR Disclosure and Firms' Growth.
    Akram A; Tang Y; Tariq J
    Front Psychol; 2020; 11():1624. PubMed ID: 32903572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.